HAE — HAEMONETICS CORP

Ownership history in Squarepoint Ops LLC  ·  22 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in HAEMONETICS CORP (HAE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.14% (2020 Q2)
Avg. % of fund
0.02%
First filed
2017 Q3
Last filed
2025 Q3
Quarters held
22
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 173,314 +155,014 +847.1% 0.01% $8.4M $48.74
2025 Q3 REDUCED 18,300 -213,015 -92.1% 0.00% $892K $48.74
2025 Q1 ADDED 231,315 +212,583 +1134.9% 0.02% $14.7M $63.55
2024 Q4 ADDED 18,732 +6,532 +53.5% 0.00% $1.5M $78.08
18 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HAE price (monthly, adj. close)

Other funds also holding HAE

As of 2025 Q4 — sorted by position size

North Peak Capital Management, LLC 3Y 7Y 7.51% KESTREL INVESTMENT MANAGEMENT CORP 3Y 7Y 4.46% QSV Equity Investors LLC 1.66% Aristotle Capital Boston, LLC 3Y 7Y 1.63% Sio Capital Management, LLC 3Y 7Y 1.17% BEACON INVESTMENT ADVISORS LLC 3Y 1.02% River Road Asset Management, LLC 3Y 7Y 0.97% Riverwater Partners LLC 3Y 0.96% ISTHMUS PARTNERS, LLC 3Y 7Y 0.6% MIZUHO MARKETS AMERICAS LLC 3Y 0.43%
← Back to Squarepoint Ops LLC Holdings